Special Considerations and Clinical Management of HIV in Patients With Substance Use Disorder
Summary
- Administration of raltegravir has no significant effect on methadone[FDA Raltegravir] or buprenorphine/naloxone[Douglas Bruce 2013]
- No significant interactions occur with coadministration of elvitegravir, cobicistat, and methadone[Bruce 2013c] or buprenorphine/naloxone[Bruce 2013b]
- No significant interactions occur between dolutegravir and methadone[Song 2013]
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content